Considering that the genetic factors of approximately 30% of CBAVD patients remain unknown, it is recommended to perform massive parallel sequencing for patients who test negative for CFTR and ADGRG2 gene screening. Here, CFTR is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.